REFERENCES
1. Mittendorfer B. Origins of metabolic complications in obesity: adipose tissue and free fatty acid trafficking. Curr Opin Clin Nutr Metab Care 2011;14:535-41.
2. Romeo GR, Lee J, Shoelson SE. Metabolic syndrome, insulin resistance, and roles of inflammation--mechanisms and therapeutic targets. Arterioscler Thromb Vasc Biol 2012;32:1771-6.
3. Gorman GS, Chinnery PF, DiMauro S, et al. Mitochondrial diseases. Nat Rev Dis Primers 2016;2:16080.
4. The Congressional Diabetes Caucus Release. About Diabetes. Available from: https://diabetescaucus-degette.house.gov/facts-and-figures. [Last accessed on 12 Mar 2021].
5. Ramachandran A, Mary S, Yamuna A, Murugesan N, Snehalatha C. High prevalence of diabetes and cardiovascular risk factors associated with urbanization in India. Diabetes Care 2008;31:893-8.
6. Münzel T, Sørensen M, Schmidt F, et al. The adverse effects of environmental noise exposure on oxidative stress and cardiovascular risk. Antioxid Redox Signal 2018;28:873-908.
7. Ferrucci L, Fabbri E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol 2018;15:505-22.
8. Gerdts E, Regitz-Zagrosek V. Sex differences in cardiometabolic disorders. at Med 2019;25:1657-66.
9. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004;4:579-91.
10. Yalcin G, Yalcin A. Metabolic syndrome and neurodegenerative diseases. J Geriatr Med Gerontol 2018;4:042.
